A single Wegovy pen typically costs between $540 and $570 without insurance, which breaks down to approximately $400-$529 per month depending on your prescribed dose. For context, Health Canadas Drug Agency estimates annual Wegovy treatment at the list price costs approximately $5,066 per patient per year (roughly $420 per month) based on the recommended maintenance dose of 2.4 mg weekly. Current Promotional Pricing: Novo Nordisk offers a Wegovy Savings Program where self-pay patients can reduce costs to $149 per month for the 1.5 mg and 4 mg doses through April 15, 2026 (offer available for eligible patients only)
When researching compounds like MOTS-c, Retatrutide, or even adjunctive peptides such as 5 amino 1 mq, obtaining high-purity, research-grade peptides is non-negotiable
My calorie intake was almost 1000-1500 max per day
Seizures, if recurrent, should be treated with intravenous benzodiazepines, and status epilepticus should be managed according to established protocols (Meierkord et al., 2010)
Give any new product at least three months of consistent use
Phase III retatrutide study demonstrates 30% weight loss. May 22, 2026